posted on 2023-03-31, 02:00authored byAhmed A. Mohamed, Charles P. Xavier, Gauthaman Sukumar, Shyh-Han Tan, Lakshmi Ravindranath, Nishat Seraj, Vineet Kumar, Taduru Sreenath, David G. McLeod, Gyorgy Petrovics, Inger L. Rosner, Meera Srivastava, Jeffrey Strovel, Sanjay V. Malhotra, Nicole A. LaRonde, Albert Dobi, Clifton L. Dalgard, Shiv Srivastava
S1. Comparison and confirmation of ERGi-USU effect on ERG protein, cell growth and gene expression, S2. Antibody based Screening and identification of small molecule inhibitors of the ERG oncoprotein expression, S3. Evaluation of dose-dependent effect of ERGi-USU on ERG transcript with ERG cell panel, S4. Evaluation of the effect of ERGi-USU on cell growth of ERG negative prostate cancer cell lines, S5. ERGi-USU selectively decreases AR protein levels, only in TMPRSS2-ERG harboring VCaP cells.